03/20/2024
3:10 PM | Fulcrum Therapeutics (Issuer)
Horn Patrick Taylor (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
03/20/2024
3:15 PM | Fulcrum Therapeutics (Issuer)
Horn Patrick Taylor (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/08/2024
5:00 PM | Fulcrum Therapeutics (Subject)
Tourangeau Greg (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/08/2024
5:05 PM | Fulcrum Therapeutics (Issuer)
Tourangeau Greg (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/27/2024
6:01 AM | Fulcrum Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2024
6:53 AM | Fulcrum Therapeutics (Subject)
RTW INVESTMENTS, LP (Filed by)
| Form SC 13G/A | |
02/13/2024
11:08 AM | Fulcrum Therapeutics (Subject)
SUVRETTA CAPITAL MANAGEMENT, LLC (Filed by)
| Form SC 13G/A | |
|
02/07/2024
6:44 AM | ADAGE CAPITAL PARTNERS GP, L.L.C. (Filed by)
Fulcrum Therapeutics (Subject)
| Form SC 13G/A | |
01/30/2024
8:00 PM | Fulcrum Therapeutics (Issuer)
Oltmans Curtis Gale (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/30/2024
8:05 PM | Fulcrum Therapeutics (Issuer)
Musso Alan A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/30/2024
8:10 PM | Fulcrum Therapeutics (Issuer)
Tourangeau Greg (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/07/2023
6:02 AM | Fulcrum Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/07/2023
6:05 AM | Fulcrum Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/02/2023
3:01 PM | Fulcrum Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/22/2023
6:01 AM | Fulcrum Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/03/2023
6:05 AM | Fulcrum Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/03/2023
6:11 AM | Fulcrum Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/10/2023
4:06 PM | Fulcrum Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/07/2023
3:35 PM | Fulcrum Therapeutics (Subject)
| Form SC 13G/A | |
07/03/2023
3:16 PM | Fulcrum Therapeutics (Issuer)
Sapir Alex (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
06/29/2023
3:16 PM | Collins James J. (Reporting)
Fulcrum Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/29/2023
3:16 PM | Fulcrum Therapeutics (Issuer)
Gould Robert J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/29/2023
3:16 PM | Ezekowitz Alan (Reporting)
Fulcrum Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/29/2023
3:16 PM | Dorton Katina (Reporting)
Fulcrum Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/29/2023
3:16 PM | Banks Sonja (Reporting)
Fulcrum Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/29/2023
3:16 PM | Fulcrum Therapeutics (Issuer)
Haviland Kate (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/29/2023
3:23 PM | Fulcrum Therapeutics (Issuer)
GERAGHTY JAMES A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/23/2023
4:31 PM | Fulcrum Therapeutics (Filer)
| Form 10-K/A | |
05/15/2023
6:06 AM | Fulcrum Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/15/2023
6:08 AM | Fulcrum Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/28/2023
3:10 PM | Fulcrum Therapeutics (Filer)
| Form DEFA14A | |
